Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract

Cataract Clinical Trial

Official title: Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract

Status Completed

Clinical Trial Summary

This study is a single-center, parallel-group, randomized controlled trial with the following objectives: to compare the incidence of post-operative descemet membrane detachment (DMD) in phacoemulsification surgery between modified and conventional 2.2mm microincision.

Clinical Trial Description

2.2mm incision is considered an ideal incision size in phacoemulsification. However, DMD is a common and serious complication in 2.2mm microincision phacoemulsification for hard nucleus age-related cataract. DMD is originated from the incision in the operation. How to construct the appropriate incision shape and size for reducing the occurrence of DMD is an important problem to be solved urgently in phacoemulsification surgery.

The investigators found that enlarging the internal incision could increase the range of motion of surgical instruments and reduce the friction of instruments to incision. Therefore，the incidence of DMD would be reduced. The investigators developed this technique, modified 2.2mm incision, to reduce the incidence of incision-site DMD and not to increase other incision related complications.

In this trial, the investigators aim to compare modified and conventional 2.2mm incision with regard to safety and efficacy in reducing the incidence of DMD. ;

Related Conditions & MeSH terms

• Cataract

• NCT number: NCT04014699
• Study type: Interventional
• Source: Zhongshan Ophthalmic Center, Sun Yat-sen University
• Status: Completed
• Phase: N/A
• Start date: July 22, 2019
• Completion date: January 22, 2020